Integra Lifesciences Holdings Corp insiders have been one-way buyers this past year: one person put roughly $102,000 into the stock and nobody sold at market prices.
The largest purchase came from GRAVES JEFFREY A (Director), about $102,000.
Big money check: 212 institutions held IART as of Q2 2026, and more funds bought than sold. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | GRAVES JEFFREY A | Director | Buy | 9,000 | $11.35 | $102K | SEC |
| Dec 4, 2024 | Schwartz Eric | Executive Officer | Sell | 4,070 | $24.60 | $100K | SEC |
| Dec 3, 2024 | McBreen Michael J. | President | Sell | 1,700 | $24.16 | $41K | SEC |
| Aug 20, 2024 | Mosebrook Jeffrey | Executive Officer | Sell | 1,191 | $21.58 | $26K | SEC |
| May 24, 2024 | ESSIG STUART | Chair | Buy | 52,641 | $28.49 | $1.5M | SEC |
| May 22, 2024 | HILL BARBARA B | Director | Buy | 36,350 | $27.40 | $996K | SEC |
| Mar 8, 2024 | DAVIS ROBERT T. JR. | President | Sell | 8,348 | $36.59 | $305K | SEC |
| Aug 10, 2023 | Mosebrook Jeffrey | Executive Officer | Sell | 1,177 | $44.46 | $52K | SEC |
| Jun 5, 2023 | Schwartz Eric | Executive Officer | Buy | 2,640 | $37.89 | $100K | SEC |
| Jun 2, 2023 | De Witte Jan | CEO | Buy | 7,792 | $38.50 | $300K | SEC |
| Mar 8, 2023 | McBreen Michael J. | President | Sell | 1,843 | $54.29 | $100K | SEC |
| Mar 3, 2023 | DAVIS ROBERT T. JR. | President | Sell | 1,566 | $55.21 | $86K | SEC |
| Feb 28, 2023 | Evoli Lisa | Executive Officer | Sell | 3,767 | $57.00 | $215K | SEC |
In the last 12 months Integra Lifesciences Holdings Corp insiders made open-market purchases worth about $102,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in IART was filed on 2025-11-06.
212 investment managers reported holding IART in SEC Form 13F filings for Q2 2026.
No congressional trades in IART were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).